.png){kind=icon}
.png){kind=icon}
Return
Tailoring radiotherapy in cT1–2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study
.png){kind=icon}
PRE
AI
A
L
J
J
T
P
A
R
A
S
R
P
L
J
A
L
DOI：10.1016/S1470-2045(26)00216-0.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Indications for postoperative locoregional radiotherapy in cT1–2N1 breast cancer after primary systemic therapy are disputed. The previously published 5-year outcomes of the RAPCHEM study showed excellent locoregional control when radiotherapy was tailored to the nodal response after primary chemotherapy. Here, we present 10-year results.
Journal
T
IF:
0
Papers:
348
Citations:
1
Organization
Cited Papers